Locum Consultant Neurologist- Special interest Sclerosis

Locum Consultant Neurologist – Special interest in Multiple Sclerosis

The closing date is 25 February 2026

University College London Hospitals NHS Foundation Trust (UCLH) is seeking to appoint a Locum Consultant in Neurology with a special interest in Multiple Sclerosis and CAR‑T Neurology with a commitment to high-quality patient care, innovative service models, delivery of performance targets, and excellence in education/training.

CV required for application.

This is a 4.5 PA locum Consultant Neurologist post. The post-holder will deliver two specialist Multiple Sclerosis clinics per week with additional time for inpatient consultations, CAR‑T work, patient administration and supporting professional activities.

The post holder will be expected to undertake all appropriate direct clinical care (DCC) activities to ensure the effective management of the patients under their care. This will primarily be through a weekly specialist MS clinic but additional inpatient care may be required.

• Direct Patient Care (DCC) – Outpatient clinic 2.0
• Inpatient ward round/consultations 0.25
• Cell-based therapies 0.25
• Total Direct Patient Care 3.75
• Supporting Professional
  
  Activities:
  
  0.75
• Total PAs: 4.5
• Additional Responsibilities:
  Nil
• Other Duties:
  Nil

UCLH is one of the most complex NHS trusts in the UK, serving a large and diverse population. We provide academically led acute and specialist services, to people from the local area, from throughout the United Kingdom and overseas. Our vision is to deliver top-quality patient care, excellent education, and world‑class research.

We provide first‑class acute and specialist services across eight sites:

• University College Hospital (incorporating the Elizabeth Garrett Anderson Wing)
• National Hospital for Neurology and Neurosurgery
• Royal National ENT and Eastman Dental Hospitals
• University College Hospital Grafton Way Building
• Royal London Hospital for Integrated Medicine
• University College Hospital Macmillan Cancer Centre
• The Hospital for Tropical Diseases
• University College Hospital at Westmoreland Street

We are dedicated to the diagnosis and treatment of many complex illnesses. UCLH specialises in women's health and the treatment of cancer, infection, neurological, gastrointestinal and oral disease. It has world class support services including critical care, imaging, nuclear medicine and pathology.

We are committed to sustainability and have pledged to become a carbon net‑zero health service, embedding sustainable practice throughout UCLH. We have set an ambitious target of net zero for our direct emissions by 2031 and indirect emissions by 2040.

For the full Person Specification and more information regarding the main responsibilities of this role, please refer to the attached Job Description.

Please note, due to anticipated high volumes of applications, this vacancy may close earlier than the listed closing date. You are advised not to delay submitting your completed application.

The Multi‑professional team attends to approximately 6,000 people with Multiple Sclerosis across the entire disease trajectory. This includes the provision and safety monitoring of MS disease‑modifying treatments (DMTs), with approximately 3,500 patients currently receiving treatments.

The consultant body works within a multi‑disciplinary environment alongside nurse specialists, therapists and pharmacists specialising in MS. There are strong links with neuro‑rehabilitation services. The multi‑disciplinary team has substantial expertise designing new models of care, using co‑design and innovation methodologies with patients and families, contributing to strategic boards across the NHS, including NICE Technology Appraisal (TA) group of NICE, Association of British Neurologists, NHS England and the Neurology Academy.

The consultant body is nationally and internationally recognised for clinical research. Examples are leadership of the Progressive MS Alliance, ECTRIMS, European MAGNIMS MRI consortium, research activity such as NIHR funded PITMS and REFINE‑MS studies, MRI development…